NX PharmaGen is Diagnostic Equipment in United States that focus on tumor imaging platform business. Founded in 2010. They cover business area such as developer, molecular diagnostic, tumor imaging platform, preterm birth, cancer, proteomic, valuable diagnostic datum, prenatal and oncology condition, biomarker-contain microvesicle, diseased cell, medical practitioner, actionable and disease-specific molecular datum.
2010
( 14 years old in 2024 )
Tumor Imaging Platform
-
4350 Brownsboro Road
Suite 110
Louisville, KY 40207
United States
Private
developermolecular diagnostictumor imaging platformpreterm birthcancerproteomicvaluable diagnostic datumprenatal and oncology conditionbiomarker-contain microvesiclediseased cellmedical practitioneractionable and disease-specific molecular datum
* We use standard office opening hours in near NX PharmaGen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NX PharmaGen is Diagnostic Equipment business from United States that founded in 2010 (14 years old in 2024), NX PharmaGen business is focusing on Tumor Imaging Platform.
NX PharmaGen headquarter office and corporate office address is located in 4350 Brownsboro Road Suite 110 Louisville, KY 40207 United States.
NX PharmaGen was founded in United States.
In 2024, NX PharmaGen is currently focus on tumor imaging platform sector.
Above is snippet of Google Trends for "tumor imaging platform" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NX PharmaGen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
